期刊文献+

miR-34b/c启动子区多态性与原发性肝细胞肝癌易感性的关联研究 被引量:23

A potentially functional polymorphism in the promoter region of miR-34b/c is associated with an increased risk for primary hepatocellular carcinoma
原文传递
导出
摘要 目的探讨miR-34b/c rs4938723 T>C与中国人群原发性肝细胞肝癌(hepatocellular carcinoma,HCC)易感性的关系。方法采用病例对照研究设计,选取501例原发性肝细胞肝癌病例和548例正常对照。选取miR-34b/c rs4938723 T>C为研究位点,以聚合酶链反应-限制性片段长度多态性(PCR-RFLP)方法进行多态性检测,应用Logistic回归计算OR值及95%CI,比较不同基因型与HCC发病风险的关系。结果在调整年龄、性别、吸烟、饮酒因素后,携带rs4938723 TC/CC基因型者与携带rs4938723 TT基因型个体相比,发生肝癌的风险增加了40%(调整OR=1.40,95%CI=1.10~1.80)。进一步分析显示在原发性肝细胞肝癌的发生中rs4938723基因型与饮酒存在交互作用(相乘交互作用P=0.049,相加交互作用P=0.012)。结论本研究表明位于miR-34b/c启动子区的rs4938723 T>C多态性可能影响中国人群原发性肝细胞肝癌发病风险。 Objective To investigate the associations between miR-34b/c rs4938723 T 〉 C and hepatocellular carcinoma (HCC) susceptibility in a Chinese population. Methods A case-control study among 501 HCC cases and 548 controls matched by age and sex was conducted, and the genotypes were determined by the polymerase chain reaction-restriction fragment length polymorphism (PCR-RFLP) assays. Logistic regression analysis was used to evaluate the odd ratios (ORs) and 95% confidence intervals (CIs) of rs4938723 T〉C with susceptibility of HCC. Results The miR-34b/c rs4938723 TC/CC genotypes were associated with a significantly increased risk of HCC compared with their corresponding wild-type bomozygotes (adjusted OR = 1.40, 95 % CI = 1.10-1.80). Furthermore, a significant interaction between alcohol drinking and rs4938723 T 〉 C on HCC risk was observed (P = 0. 049 for multiplicative and P = 0. 012 for additive interaction). Conclusions These findings indicate that the potentially functional SNP rs4938723 in the promoter region of miR-34b/c are associated with the development of HCC in this Chinese population.
出处 《中华疾病控制杂志》 CAS 2011年第7期551-554,共4页 Chinese Journal of Disease Control & Prevention
基金 国家自然科学基金(30800946) 霍英东教育基金会高等院校青年教师基金(122031) 江苏省卫生厅2009年面上项目(H200957) 江苏省333工程项目(DG216D5023)
关键词 启动区(遗传学) 多态性 单核苷酸 肝细胞 疾病易感性 Promoter regions (genetics) Polymorphism, single nucleotide Carcinoma, hepatocellular Disease susceptibility
  • 相关文献

参考文献19

  • 1Parkin DM, Bray F, Ferlay J, et al. Global cancer statistics, 2002 [J]. CA Cancer J Clin, 2005,55(2) :74-108.
  • 2Bommer GT, Gerin I, Feng Y, et al. p53-mediated activation of miRNA34 candidate tumor-suppressor genes [ J 1. Curr Biol, 2007,17(15) : 1298-1307.
  • 3He L, He X, Lim LP, et al. A mieroRNA component of the p53 tttmour suppressor network [ J ]. Nature, 2007, 447 (7148) : 1130-1134.
  • 4Chang TC, Wentzel EA, Kent OA, et al. Transactivation of miR-34a by p53 broadly influences gene expression and promotesapoptosis [J]. Mol Cell, 2007,26(5) :745-752.
  • 5Raver-Shapira N, Marciano E, Meiri E, et al. Transcriptional activation of miR-34a contributes to p53-mediated apoptosis [ J 1. Mol Cell, 2007,26(5):731-743.
  • 6Tarasov V, Jung P, Verdoodt B, et al. Differential regulation of microRNAs by p53 revealed by massively parallel sequencing: miR-34a is a p53 target that induces apoptosis and Gl-arrest [Jl. Cell Cycle, 2007,6(13) :1586-1593.
  • 7Corney 13(2, Flesken-Nikitin A, Godwin AK, et al. MicroRNA 34b and MicroRNA-34c are targets of p53 and cooperate in con trol of cell proliferation and adhesion-independent growth [J].Cancer Res, 2007,67(18) z8433-8438.
  • 8Hu Z, Chen J, Tian T, et al. Genetic variants of miRNA se- quences and non-small cell lung cancer survival [J ]. J Clin Invest, 2008,118 (7) : 2600-2608.
  • 9Tian T, Shu Y, Chen J, et al. A functional genetic variant in mi- croRNA-196a2 is associated with increased susceptibility of lung cancer in Chinese [J]. Cancer Epidemiol Biomarkers Prev, 2009, 18(4) : 1183-1187.
  • 10Bossard P, Zaret KS. GATA transcription [actors as 10otentiators of gut endoderm differentiation [J]. Development, 1998, 125 (24) : 4909-4917.

同被引文献102

  • 1张荣贵.STAT3和胃癌的研究进展[J].中华临床医师杂志(电子版),2011,5(13):3898-3900. 被引量:6
  • 2徐会,王赫,周福祥,杨俊涛.微RNA与非酒精性脂肪性肝病[J].中华肝脏病杂志,2014,22(6). 被引量:3
  • 3陈建国,朱健,张永辉,朱源荣,陆建华.江苏省启东地区1973至2002年肝癌发病率长期趋势的评价[J].中华医学杂志,2005,85(43):3052-3056. 被引量:53
  • 4饶克勤 李连弟.中国恶性肿瘤危险因素研究[M].北京:中国协和医科大学出版社,2003.190-191.
  • 5Carthew RW. Gene regulation by microRNAs [ J ]. Curr OpinGenet Dev, 2006,16(2) :203-208.
  • 6Calin GA, Dumitru CD,Shimizu M,et al. Frequent deletions anddown-regulation of micro-RNA genes miR15 and miR16 at 13ql4in chronic lymphocytic leukemia [ J]. Proc Natl Acad Sci U S A,2002,99(24) : 15524-15529.
  • 7Calin GA, Croce CM. MicroRNA signatures in human cancers [J].Nat Rev Cancer, 2006,6(11) :857-866.
  • 8Gaur A,Jewell DA,Liang Y,et al. Characterization of microRNAexpression levels and their biological correlates in human cancercell lines [ J]. Cancer Res, 2007,67(6) :2456-2468.
  • 9Coussens LM,Werb Z. Inflammation and cancer [ J ]. Nature,2002,420(6917) :860-867.
  • 10Hussain SP, Harris CC. Inflammation and cancer: an ancient linkwith novel potentials [ J]. Int J Cancer, 2007 ,121 (11 ) : 2373-2380.

引证文献23

二级引证文献61

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部